Financing channel feed – Endpoints News

Financing channel feed

Oncology biotech Bicara unveils IPO pitch same day as Zenas

9 months ago

Autoimmune biotech Zenas files for IPO amid summer lull for public debuts

9 months ago

Illumina Ventures sets out for $300M third fund

9 months ago

Versant and Novartis build 'Chinook 2.0' for RNA therapies in kidney diseases

9 months ago

BridgeBio forms another offshoot with $300M in commitments

9 months ago

After Pfizer layoffs, Array chemists regather at next-gen obesity biotech Ambrosia Biosciences

9 months ago

TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease

9 months ago

TYK Medicines seeks to launch new EGFR drug in China with $74M Hong Kong IPO

9 months ago

Investment in early-stage health tech startups climbed in the first half of 2024, report shows

9 months ago

Sanofi backs AnaptysBio’s $100M offering, helping catapult the biotech’s stock

9 months ago

Exclusive: Gates Foundation backs startup using optogenetics to manufacture biologics

9 months ago

Why a new health tech venture firm is investing only in founders with a healthcare background

9 months ago

Halda adds $126M to test oral drugs for prostate, breast cancer

9 months ago

Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion

9 months ago

IDRx raises $120M for targeted GIST drug following leadership change

9 months ago

TPG reveals $580M life sciences fund, which has already backed multiple biotechs

9 months ago

Eisai picks SEED Therapeutics for molecular glue deal worth as much as $1.5B

9 months ago

Arie Belldegrun and team unveil $600M life sciences credit firm amid struggling biotech market

9 months ago

Exclusive: TCG, DCVC and Lux back new autoimmune biotech from Kallyope co-founder

9 months ago

Japanese government grants Shinobi $59M for cell therapy development

9 months ago

A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals

9 months ago

MBX Biosciences rakes in $63.5M for peptide therapies

9 months ago

Exclusive: Devoted Health raises $112M, plots insurance markets expansion

9 months ago

Apogee and Spyre founder launches another autoimmune biotech, and it's got $80M to start

9 months ago

First page Previous page 9 10 111213 14 15 Next page Last page